DCPH

Deciphera Pharmaceuticals, Inc. Common Stock
DCPH

Overview Fund Activity
Delisted

DCPH was delisted on the 10th of June, 2024.

Back to rankings

161 hedge funds and large institutions have $2.18B invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 64 increasing their positions, 54 reducing their positions, and 22 closing their positions.

Holders
161
Holders Change
-7
Holders Change %
-4.17%
% of All Funds
3.26%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.14%
New
16
Increased
64
Reduced
54
Closed
22
Calls
$22.6M
Puts
$21.3M
Net Calls
+$1.32M
Net Calls Change
+$826K

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$59.7M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$194M
3
PAMU
3
Pictet Asset Management (UK)
United Kingdom
$43M
4
AllianceBernstein
4
AllianceBernstein
Tennessee
$79.3M
5
SAM
5
Sectoral Asset Management
Quebec, Canada
$21.3M

Top Sellers

1
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
$3.1M
2
FCM
2
Farallon Capital Management
California
$16.9M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$61M
4
PHS
4
PFM Health Sciences
California
$0
5
RSCM
5
Rock Springs Capital Management
Maryland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
RG
1
Redmile Group
California
$245M 4,774,918 -204,023 -4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$194M 3,774,261 +224,700 +6%
Franklin Resources
3
Franklin Resources
California
$174M 3,382,551 -148,937 -4%
BlackRock
4
BlackRock
New York
$167M 3,259,572 +170,366 +6%
ACA
5
Avoro Capital Advisors
New York
$93.4M 1,820,000 -40,000 -2%
State Street
6
State Street
Massachusetts
$90.8M 1,769,162 +48,524 +3%
AllianceBernstein
7
AllianceBernstein
Tennessee
$79.3M 1,544,836 +191,759 +14%
ACH
8
ArrowMark Colorado Holdings
Colorado
$79M 1,540,218 -28,451 -2%
NLVP
9
New Leaf Venture Partners
New York
$62.1M 1,209,571 – –
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$61M 1,189,487 -349,213 -23%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$59.7M 1,163,356 +351,956 +43%
O
12
OrbiMed
New York
$57.7M 1,125,700 – –
PAMU
13
Pictet Asset Management (UK)
United Kingdom
$43M 838,859 +217,049 +35%
Alkeon Capital Management
14
Alkeon Capital Management
New York
$34.4M 670,975 – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$31.7M 617,287 +166,519 +37%
AG
16
Artal Group
Luxembourg
$30.8M 600,000 -50,000 -8%
DM
17
Deerfield Management
New York
$27.1M 528,585 +106,906 +25%
Wells Fargo
18
Wells Fargo
California
$26.5M 517,294 +19,058 +4%
TCM
19
TimesSquare Capital Management
New York
$25.2M 490,400 -70,130 -13%
Northern Trust
20
Northern Trust
Illinois
$23.5M 457,829 +9,559 +2%
SHI
21
SV Health Investors
Massachusetts
$23.1M 449,951 – –
Norges Bank
22
Norges Bank
Norway
$22.8M 444,860 +56,781 +15%
SAM
23
Sectoral Asset Management
Quebec, Canada
$21.3M 416,059 +191,700 +85%
EP
24
Eversept Partners
New York
$20.6M 402,433 -16,219 -4%
Lord, Abbett & Co
25
Lord, Abbett & Co
New Jersey
$20.5M 399,999 +15,194 +4%
1
2 3 4 5